[Clinical observations with rifampicin, a new bactericidal antibiotic].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001991:Bronchitis / Q000188:drug therapy*; D001996:Bronchopneumonia / Q000188:drug therapy*; D004755:Enterobacteriaceae / Q000302:isolation & purification; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D006193:Haemophilus influenzae / Q000302:isolation & purification; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D009362:Neoplasm Metastasis; D010997:Pleural Neoplasms / Q000188:drug therapy*; D010998:Pleurisy / Q000188:drug therapy*; D011001:Pleuropneumonia / Q000188:drug therapy*; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy*; D011656:Pulmonary Emphysema / Q000188:drug therapy*; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013183:Sputum / Q000382:microbiology; D013210:Staphylococcus / Q000302:isolation & purification
D012293:Rifampin
Klinische Beobachtungen mit Rifampicin, einem neuen bakterizid wirkenden Antibiotikum.